top of page
Peach-16-9-2.png
teal-logo_white.png

Multi-Omics Meets Real-World Discovery

We transform complex multiomics data into actionable understanding - accelerating research, clarifying biology, and enabling next-generation therapies.

Empowering Teams with Deep Capabilities Across High-Complexity Use Cases

Identify Biomarkers for Risk or Disease 

Discover proteins associated with clinical traits, outcomes, or disease risk - enabling better stratification and earlier intervention.

Track Aging and Resilience Across Organs 

Assess how individual organs are aging relative to peers - detecting early decline, hidden vulnerability, or resilience over time.

Measure the Impact

of Interventions

Quantify how a treatment, exposure, or lifestyle factor shifts biological signatures across organs - even before symptoms appear.

Uncover Mechanisms of Observed Changes

Assess how individual organs are aging relative to peers - detecting early decline, hidden vulnerability, or resilience over time.

Prioritize Proteins with Evidence of Causality

Determine whether a protein

is likely to cause a given phenotype or outcome, using genetic instruments to go beyond correlation.

Add Molecular Insight

to Existing Studies

Layer Teal’s analytics onto proprietary or external data to extract deeper insight from cohort studies, trials, or biobank data.

Why Teal Rise

Built on One of the World's Largest Proteogenomic Datasets

100K+

Proteomics Dataset

50K+

Matched Genotypes

20+

Diverse Cohorts

Breakthrough Proteomics-Led Organ Aging Clocks

11+

Organ Systems

11K+

Proteins per Samples

45K+

Validation Cohort

Built-In Causal Inference Capabilities

Mendelian randomization and pQTL-based analytics turn associations into insight. 

Peach-3-2-3.png

Teal's approach has been validated in more than 45.000 individuals 

Teal's technology was developed in the lab of Dr. Tony Wyss-Coray at Stanford University, with foundational results published on the cover of Nature in December 2023.

They have since been validated in over 45,000 participants in the UK Biobank and shown to respond to interventions - setting a new standard for tracking organ-level health.

Nature Internal Clocks Cover .jpg

2023
Nature Medicine

Organ Aging Signatures in the Plasma Proteome Track Health and Disease

The Lancet March 2025 Cover_edited_edite

2024
Lancet Digital Health

Proteomic organ-specific ageing signatures and 20-year risk of age-related diseases: the Whitehall II observational cohort study

Nature Medicine Paper Image.webp

2025
Nature Medicine

Plasma proteomics links brain and immune system aging with healthspan and longevity

In the Press

Ground Truths by Eric Topol

The Emergence of Protein Organ Clocks

SciAm Logo White.jpg

Scientific American

Your Organs Might Be Aging at Different Rates

Independent Logo Black Background.png

The Independent

Blood tests can show how fast your organs are ageing, study says

Stanford Logo Black Background.png

Stanford Medicine News Center

Stanford Medicine-led study finds way to predict which of our organs will fail first

The Guardian Logo Black Background.png

The Guardian

Blood test to determine organ age could help predict disease risk

Ground Truths by Eric Topol

What Can 11,000 Proteins In Our Blood Tell Us?

Longevity Tech Logo Black Background.png

Longevity Technology

Stanford organ aging study spawns new longevity startup

bbc-logo black.jpg

BBC

Blood test shows if organs are ageing fast or slowly

Screenshot 2024-12-02 at 2.10.22 PM.png

​The Washington Post

Inside your body, aging unfolds at remarkably different rates

Team 

Untitled design (16)_edited.png

Tony Wyss-Coray

Co-Founder & Scientific Advisor

Untitled design (20).png

Markus Okumus

Co-Founder 

 

Wenyu_edited.jpg

Wenyu Zhou 

Head of R&D

Contact

Peach-16-9-3.png
teal-logo_white.png

© 2025 Teal Rise. All rights reserved.

©2024 by Teal Omics.

bottom of page